Screen Inc is a Seattle-based company that specializes in cognitive testing, offering an easy-to-use computer-assisted, touchscreen test called the CANS-MCI. Their test battery and testing process provide comprehensive and reliable cognitive reports, which can be used for various purposes such as assessing mild cognitive impairments, concussion assessment, preclinical diagnosis of Alzheimer's disease, and tracking cognitive health. The CANS-MCI is professionally evaluated, reimbursable, and provides timely reports, making it an efficient and cost-effective option for early detection and awareness of impending dementia.
With eight distinct tests administered in a single session, the CANS-MCI takes 30 minutes or less and is available in multiple languages. It requires no computer skills and offers standardized administration for maximum objectivity and reliability. The test has been validated against various neuropsychological exams and hardware requirements are minimal, making it accessible for healthcare professionals and patients alike. Screen Inc aims to provide accurate and affordable cognitive screening measures to help doctors detect cognitive decline early and make informed decisions about patient care.
Generated from the website